Literature DB >> 30698728

Double Trouble: Contralateral Breast Cancer Risk Management in the Modern Era.

Kevin J Cheung1, Nancy E Davidson1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30698728      PMCID： PMC6624165          DOI： 10.1093/jnci/djy203

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

1.  The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype.

Authors:  Iris Kramer; Michael Schaapveld; Hester S A Oldenburg; Gabe S Sonke; Danielle McCool; Flora E van Leeuwen; Koen K Van de Vijver; Nicola S Russell; Sabine C Linn; Sabine Siesling; C Willemien Menke-van der Houven van Oordt; Marjanka K Schmidt
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

2.  Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

Authors:  Joanne L Blum; Patrick J Flynn; Greg Yothers; Lina Asmar; Charles E Geyer; Samuel A Jacobs; Nicholas J Robert; Judith O Hopkins; Joyce A O'Shaughnessy; Chau T Dang; Henry Leonidas Gómez; Louis Fehrenbacher; Svetislava J Vukelja; Alan P Lyss; Devchand Paul; Adam M Brufsky; Jong-Hyeon Jeong; Linda H Colangelo; Sandra M Swain; Eleftherios P Mamounas; Stephen E Jones; Norman Wolmark
Journal:  J Clin Oncol       Date:  2017-04-11       Impact factor: 44.544

3.  Incidence and prognosis of synchronous and metachronous bilateral breast cancer.

Authors:  Mikael Hartman; Kamila Czene; Marie Reilly; Jan Adolfsson; Jonas Bergh; Hans-Olov Adami; Paul W Dickman; Per Hall
Journal:  J Clin Oncol       Date:  2007-09-20       Impact factor: 44.544

4.  Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.

Authors:  A Font-Gonzalez; L Liu; A C Voogd; M K Schmidt; J A Roukema; J W W Coebergh; E de Vries; I Soerjomataram
Journal:  Breast Cancer Res Treat       Date:  2013-06-13       Impact factor: 4.872

5.  Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer.

Authors:  K C Aalders; A C M van Bommel; T van Dalen; G S Sonke; P J van Diest; L J Boersma; M van der Heiden-van der Loo
Journal:  Eur J Cancer       Date:  2016-06-11       Impact factor: 9.162

6.  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Matthew P Goetz; John A Olson; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter M Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; Jeffrey L Berenberg; Jeffrey Abrams; George W Sledge
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

7.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

8.  Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.

Authors:  Quy H Nguyen; Nicholas Pervolarakis; Kerrigan Blake; Dennis Ma; Ryan Tevia Davis; Nathan James; Anh T Phung; Elizabeth Willey; Raj Kumar; Eric Jabart; Ian Driver; Jason Rock; Andrei Goga; Seema A Khan; Devon A Lawson; Zena Werb; Kai Kessenbrock
Journal:  Nat Commun       Date:  2018-05-23       Impact factor: 14.919

9.  The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Authors:  Michael Schaapveld; Otto Visser; W J Louwman; Pax H B Willemse; Elisabeth G E de Vries; Winette T A van der Graaf; Renée Otter; Jan Willem W Coebergh; Flora E van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  2007-08-09       Impact factor: 4.872

10.  Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq.

Authors:  Mihriban Karaayvaz; Simona Cristea; Shawn M Gillespie; Anoop P Patel; Ravindra Mylvaganam; Christina C Luo; Michelle C Specht; Bradley E Bernstein; Franziska Michor; Leif W Ellisen
Journal:  Nat Commun       Date:  2018-09-04       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.